Design and synthesis of 2-amino-4,6-diarylpyrimidine derivatives as potent α-glucosidase and α-amylase inhibitors: structure-activity relationship, in vitro, QSAR, molecular docking, MD simulations and drug-likeness studies.

In the present study, a series of 2-amino-4,6-diarylpyrimidine derivatives was designed, synthesized, characterized and evaluated for their in vitro α-glucosidase and α-amylase enzyme inhibition assays. The outcomes proved that this class of compounds exhibit considerable inhibitory activity against both enzymes. Among the target compounds, compounds 4p and 6p demonstrated the most potent dual inhibition with IC50 = 0.087 ± 0.01 μM for α-glucosidase; 0.189 ± 0.02 μM for α-amylase and IC50 = 0.095 ± 0.03 μM for α-glucosidase; 0.214 ± 0.03 μM for α-amylase, respectively as compared to the standard rutin (IC50 = 0.192 ± 0.02 μM for α-glucosidase and 0.224 ± 0.02 μM for α-amylase). Remarkably, the enzyme inhibition results indicate that test compounds have stronger inhibitory effect on the target enzymes than the positive control, with a significantly lower IC50 value. Moreover, these series of compounds were found to inhibit α-glucosidase activity in a reversible mixed-type manner with IC50 between 0.087 ± 0.01 μM to 1.952 ± 0.26 μM. Furthermore, molecular docking studies were performed to affirm the binding interactions of this scaffold to the active sites of α-glucosidase and α-amylase enzymes. The quantitative structure-activity relationship (QSAR) investigations showed a strong association between 1p-15p structures and their inhibitory actions (IC50) with a correlation value (R2) of 0.999916. Finally, molecular dynamic (MD) simulations were carried out to assess the dynamic behavior, stability of the protein-ligand complex, and binding affinity of the most active inhibitor 4p. The experimental and theoretical results therefore exposed a very good compatibility. Additionally, the drug-likeness assay revealed that some compounds exhibit a linear association with Lipinski's rule of five, indicating good drug-likeness and bioactivity scores for pharmacological targets.Communicated by Ramaswamy H. Sarma.

[1]  Syed Wadood Ali Shah,et al.  Discovery of chalcone derivatives as potential α-glucosidase and cholinesterase inhibitors: Effect of hyperglycemia in paving a path to dementia , 2023, Journal of Molecular Structure.

[2]  Yeliz Demir,et al.  Exploration of 1,2,3-triazole linked benzenesulfonamide derivatives as isoform selective inhibitors of human carbonic anhydrase. , 2022, Bioorganic & medicinal chemistry.

[3]  S. Kiran,et al.  Synthesis of 2-Aminopyrimidine Derivatives and Their Evaluation as β-Glucuronidase Inhibitors: In Vitro and In Silico Studies , 2022, Molecules.

[4]  E. Mughal,et al.  Synthesis and biological evaluation of substituted aurone derivatives as potential tyrosinase inhibitors: in vitro, kinetic, QSAR, docking and drug-likeness studies. , 2022, Journal of biomolecular structure & dynamics.

[5]  Aritra Kumar Dan,et al.  Seeking heterocyclic scaffolds as antivirals against dengue virus , 2022, European Journal of Medicinal Chemistry.

[6]  Wei Hou,et al.  Incorporating Selenium into Heterocycles and Natural Products─From Chemical Properties to Pharmacological Activities. , 2022, Journal of medicinal chemistry.

[7]  F. Saleem,et al.  Dicyanoanilines as potential and dual inhibitors of α-amylase and α-glucosidase enzymes: Synthesis, characterization, in vitro, in silico, and kinetics studies , 2021, Arabian Journal of Chemistry.

[8]  N. Uddin,et al.  Synthesis of indole derivatives as diabetics II inhibitors and enzymatic kinetics study of α-glucosidase and α-amylase along with their in-silico study. , 2021, International journal of biological macromolecules.

[9]  E. Iwuoha,et al.  Alpha-Glucosidase and Alpha-Amylase Inhibitory Activities, Molecular Docking, and Antioxidant Capacities of Salvia aurita Constituents , 2020, Antioxidants.

[10]  S. Muhammad,et al.  Design and synthesis of new flavonols as dual ɑ-amylase and ɑ-glucosidase inhibitors: Structure-activity relationship, drug-likeness, in vitro and in silico studies , 2020 .

[11]  Xin-Qiu Yao,et al.  The Bio3D packages for structural bioinformatics , 2020, Protein science : a publication of the Protein Society.

[12]  Yi Wang,et al.  Scalable molecular dynamics on CPU and GPU architectures with NAMD. , 2020, The Journal of chemical physics.

[13]  Reda M. Abdel-Rahman,et al.  Design, Synthesis, Chemistry and Biological Evaluation of Some Polyfunctional Heterocyclic Nitrogen Systems—Overview , 2020 .

[14]  T. N. Omar,et al.  Synthesis, Characterization and Preliminary Study of the Anti-Inflammatory Activity of New Pyrazoline Containing Ibuprofen Derivatives , 2019, Iraqi Journal of Pharmaceutical Sciences ( P-ISSN: 1683 - 3597 , E-ISSN : 2521 - 3512).

[15]  A. Uzairu,et al.  Theoretical modeling and molecular docking simulation for investigating and evaluating some active compounds as potent anti-tubercular agents against MTB CYP121 receptor , 2018, Future Journal of Pharmaceutical Sciences.

[16]  D. Gong,et al.  Exploring inhibitory mechanism of gallocatechin gallate on a-amylase and a-glucosidase relevant to postprandial hyperglycemia , 2018, Journal of Functional Foods.

[17]  A. Al-Qahtani,et al.  Structure activity relationship (SAR) and quantitative structure activity relationship (QSAR) studies showed plant flavonoids as potential inhibitors of dengue NS2B-NS3 protease , 2018, BMC Structural Biology.

[18]  Sung Ho Lee,et al.  Regulatory effects of 4-methoxychalcone on adipocyte differentiation through PPARγ activation and reverse effect on TNF-α in 3T3-L1 cells. , 2017, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[19]  B. Narasimhan,et al.  Synthesis, antimicrobial evaluation and QSAR studies of p-coumaric acid derivatives , 2017 .

[20]  Ismail,et al.  Synthesis of novel spiro[pyrazolo[4,3-d]pyrimidinones and spiro[benzo[4,5]thieno[2,3-d]pyrimidine-2,3'-indoline]-2',4(3H)-diones and their evaluation for anticancer activity. , 2017, Bioorganic & medicinal chemistry letters.

[21]  C. Ganesh Kumar,et al.  Design, synthesis and evaluation of novel pyrazolo-pyrimido[4,5-d]pyrimidine derivatives as potent antibacterial and biofilm inhibitors. , 2017, Bioorganic & medicinal chemistry letters.

[22]  Rahul D. Kamble,et al.  Antidiabetic and allied biochemical roles of new chromeno-pyrano pyrimidine compounds: synthesis, in vitro and in silico analysis , 2017, Medicinal Chemistry Research.

[23]  Min Zhang,et al.  Ag-Assisted Fluorination of Unprotected 4,6-Disubstituted 2-Aminopyrimidines with Selectfluor. , 2017, The Journal of organic chemistry.

[24]  Raj Kumar,et al.  Pyrimidine-fused Derivatives: Synthetic Strategies and Medicinal Attributes. , 2016, Current topics in medicinal chemistry.

[25]  Zaheer Ul-Haq,et al.  Synthesis of pyrimidine-2,4,6-trione derivatives: Anti-oxidant, anti-cancer, α-glucosidase, β-glucuronidase inhibition and their molecular docking studies. , 2016, Bioorganic chemistry.

[26]  Jin-Ming Gao,et al.  Synthesis of pyrazolo[1,5-a]pyrimidine derivatives and their antifungal activities against phytopathogenic fungi in vitro , 2016, Molecular Diversity.

[27]  Y. Pydisetty,et al.  Ionic liquid-promoted multicomponent synthesis of fused tetrazolo[1,5-a]pyrimidines as α-glucosidase inhibitors. , 2016, Bioorganic & medicinal chemistry letters.

[28]  E. Ebenso,et al.  Adsorption Behavior of Glucosamine-Based, Pyrimidine-Fused Heterocycles as Green Corrosion Inhibitors for Mild Steel: Experimental and Theoretical Studies , 2016 .

[29]  H. Fun,et al.  Synthesis, in vitro biological activities and in silico study of dihydropyrimidines derivatives. , 2015, Bioorganic & medicinal chemistry.

[30]  Naseem Ahmed,et al.  Mild and Efficient Reductive Deoxygenation of Epoxides to Olefins with Tin(II) Chloride/Sodium Iodide as a Novel Reagent , 2015, Synthesis.

[31]  R. Yousefi,et al.  Design and synthesis of new antidiabetic α-glucosidase and α-amylase inhibitors based on pyrimidine-fused heterocycles , 2015, Medicinal Chemistry Research.

[32]  Mukesh C. Sharma,et al.  Molecular Modeling Studies of Thiophenyl C-Aryl Glucoside SGLT2 Inhibitors as Potential Antidiabetic Agents , 2014, International journal of medicinal chemistry.

[33]  V. Pathak,et al.  Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents. , 2014, Bioorganic & medicinal chemistry letters.

[34]  M. Bajda,et al.  Novel synthesis of dihydropyrimidines for α-glucosidase inhibition to treat type 2 diabetes: in vitro biological evaluation and in silico docking. , 2014, Bioorganic chemistry.

[35]  A. Azam,et al.  Synthesis, characterization of 4,6-disubstituted aminopyrimidines and their sulphonamide derivatives as anti-amoebic agents , 2014, Medicinal Chemistry Research.

[36]  Xin-Hang Li,et al.  Synthesis and Crystal Structures of (E)-1-Phenyl-3-[(2,4,6-Trimethylphenyl)]prop-2-En-1-One and (E)-1-Phenyl-3-[(4-Trifluoromethylphenyl)]prop-2-En-1-One , 2014 .

[37]  F. Mokhtari,et al.  Pyrimidine-fused heterocycle derivatives as a novel class of inhibitors for α-glucosidase , 2013, Journal of enzyme inhibition and medicinal chemistry.

[38]  R. Yousefi,et al.  Synthesis of new pyrimidine-fused derivatives as potent and selective antidiabetic α-glucosidase inhibitors. , 2013, Carbohydrate research.

[39]  R. Guedes,et al.  Five-membered iminocyclitol α-glucosidase inhibitors: synthetic, biological screening and in silico studies. , 2013, Bioorganic & medicinal chemistry.

[40]  Xianqing Deng,et al.  Synthesis and evaluation of anticonvulsant and antidepressant activities of 5-alkoxytetrazolo[1,5-c]thieno[2,3-e]pyrimidine derivatives. , 2012, European journal of medicinal chemistry.

[41]  Oliver Schnell,et al.  Alpha-glucosidase inhibitors 2012 – cardiovascular considerations and trial evaluation , 2012, Diabetes & vascular disease research.

[42]  Waquar Ahsan,et al.  Antihypertensive activity of newer 1,4-dihydro-5-pyrimidine carboxamides: synthesis and pharmacological evaluation. , 2010, European journal of medicinal chemistry.

[43]  Abdel-Rhman B. A. El-Gazzar,et al.  Synthesis of substituted thieno[2,3-d]pyrimidine-2,4-dithiones and their S-glycoside analogues as potential antiviral and antibacterial agents. , 2010, European journal of medicinal chemistry.

[44]  M. Mohamed,et al.  Synthesis and biological evaluation of some thio containing pyrrolo [2,3-d]pyrimidine derivatives for their anti-inflammatory and anti-microbial activities. , 2010, European journal of medicinal chemistry.

[45]  C. Kaiser,et al.  Synthesis, biological activity, and molecular modeling studies of 1H-1,2,3-triazole derivatives of carbohydrates as alpha-glucosidases inhibitors. , 2010, Journal of medicinal chemistry.

[46]  A. Deshpande,et al.  Epidemiology of Diabetes and Diabetes-Related Complications , 2008, Physical Therapy.

[47]  J. Buolamwini,et al.  Quantitative structure-activity relationship studies on nitrofuranyl anti-tubercular agents. , 2008, Bioorganic & medicinal chemistry.

[48]  Tony Taldone,et al.  Alpha-glucosidase inhibitory activity of Syzygium cumini (Linn.) Skeels seed kernel in vitro and in Goto-Kakizaki (GK) rats. , 2008, Carbohydrate research.

[49]  Q. Dang,et al.  Synthesis of novel pyrimidine fused 8-membered heterocycles via iminium ion cyclization reactions. , 2008, The Journal of organic chemistry.

[50]  J. Bourguignon,et al.  2-Amino-6-iodo-4-tosyloxypyrimidine: a versatile key intermediate for regioselective functionalization of 2-aminopyrimidines in 4- and 6-positions , 2007 .

[51]  Jim Bellows,et al.  Is Patient Activation Associated With Outcomes of Care for Adults With Chronic Conditions? , 2007, The Journal of ambulatory care management.

[52]  Matthew P. Repasky,et al.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. , 2006, Journal of medicinal chemistry.

[53]  Jian Wang,et al.  Highly Enantioselective Organocatalytic Michael Addition Reactions of Ketones with Chalcones , 2006 .

[54]  Holger Gohlke,et al.  The Amber biomolecular simulation programs , 2005, J. Comput. Chem..

[55]  T. Barrett,et al.  Monogenic syndromes of abnormal glucose homeostasis: clinical review and relevance to the understanding of the pathology of insulin resistance and β cell failure , 2005, Journal of Medical Genetics.

[56]  Mustafa Usta,et al.  Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2. , 2005, Biochemical pharmacology.

[57]  N. Asano.  Glycosidase inhibitors: update and perspectives on practical use. , 2003, Glycobiology.

[58]  Wei Zhang,et al.  A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations , 2003, J. Comput. Chem..

[59]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[60]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[61]  Avnish Patel,et al.  Studies on Novel N4-[4,6-Diaryl-2-pyrimidinyl]-7-chloro-4-quinolinamine and their Microbicidal Efficacy , 2009 .